Journey Medical Corp (DERM)
5.50
+0.30
(+5.77%)
USD |
NASDAQ |
Nov 22, 14:12
Journey Medical Profit Margin (Quarterly): -16.34% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -16.34% |
| June 30, 2024 | -22.63% |
| March 31, 2024 | -80.14% |
| December 31, 2023 | -14.05% |
| September 30, 2023 | 48.61% |
| June 30, 2023 | -48.70% |
| March 31, 2023 | -82.99% |
| December 31, 2022 | -66.65% |
| September 30, 2022 | -62.55% |
| Date | Value |
|---|---|
| June 30, 2022 | -41.16% |
| March 31, 2022 | -5.92% |
| December 31, 2021 | -124.2% |
| September 30, 2021 | -54.29% |
| June 30, 2021 | -77.61% |
| March 31, 2021 | 2.50% |
| December 31, 2020 | 18.23% |
| September 30, 2020 | 0.31% |
| June 30, 2020 | 4.83% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-124.2%
Minimum
Dec 2021
48.61%
Maximum
Sep 2023
-34.59%
Average
-31.89%
Median
Profit Margin (Quarterly) Benchmarks
| Fortress Biotech Inc | -87.96% |
| Heron Therapeutics Inc | -14.78% |
| Eton Pharmaceuticals Inc | 6.07% |
| Elutia Inc | 21.72% |
| NovaBay Pharmaceuticals Inc | -49.65% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -125.8% |
| Return on Assets | -27.08% |
| Return on Invested Capital | -64.68% |
| Gross Profit Margin (Quarterly) | 63.87% |
| Operating Margin (Quarterly) | -19.78% |
| Return on Net Operating Assets | -44.68% |